215 related articles for article (PubMed ID: 30172068)
21. Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Exocytosis-Inhibiting, Lysosome Impairment-Based Cancer Therapy.
Ding L; Zhu X; Wang Y; Shi B; Ling X; Chen H; Nan W; Barrett A; Guo Z; Tao W; Wu J; Shi X
Nano Lett; 2017 Nov; 17(11):6790-6801. PubMed ID: 29058908
[TBL] [Abstract][Full Text] [Related]
22. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.
Woods SJ; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2015 Jul; 1849(7):821-9. PubMed ID: 25464032
[TBL] [Abstract][Full Text] [Related]
23. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy.
Lu HY; Chang YJ; Fan NC; Wang LS; Lai NC; Yang CM; Wu LC; Ho JA
Biomaterials; 2015 Feb; 42():30-41. PubMed ID: 25542791
[TBL] [Abstract][Full Text] [Related]
24. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
[TBL] [Abstract][Full Text] [Related]
25. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
26. Targeting the nucleolus for cancer intervention.
Quin JE; Devlin JR; Cameron D; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2014 Jun; 1842(6):802-16. PubMed ID: 24389329
[TBL] [Abstract][Full Text] [Related]
27. Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells.
Negi SS; Brown P
Oncotarget; 2015 Oct; 6(33):34846-58. PubMed ID: 26472108
[TBL] [Abstract][Full Text] [Related]
28. Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma.
Zhang P; Cao F; Zhang J; Tan Y; Yao S
Heliyon; 2023 Aug; 9(8):e18490. PubMed ID: 37576252
[TBL] [Abstract][Full Text] [Related]
29. Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a
Li Z; Wang B; Zhang Z; Wang B; Xu Q; Mao W; Tian J; Yang K; Wang F
Mol Ther; 2018 May; 26(5):1385-1393. PubMed ID: 29567310
[TBL] [Abstract][Full Text] [Related]
30. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways.
He L; Lai H; Chen T
Biomaterials; 2015 May; 51():30-42. PubMed ID: 25770995
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
33. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
34. Central command.
Leslie M
Science; 2014 Aug; 345(6196):506-7. PubMed ID: 25082681
[No Abstract] [Full Text] [Related]
35. Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines.
Hwang DW; So KS; Kim SC; Park KM; Lee YJ; Kim SW; Choi CM; Rho JK; Choi YJ; Lee JC
Pancreas; 2017 Apr; 46(4):575-581. PubMed ID: 28196025
[TBL] [Abstract][Full Text] [Related]
36. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
[TBL] [Abstract][Full Text] [Related]
37. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
38. Engineering Polyzwitterion and Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles as a pH-Sensitive Drug Delivery.
Ji F; Sun H; Qin Z; Zhang E; Cui J; Wang J; Li S; Yao F
Polymers (Basel); 2018 Mar; 10(3):. PubMed ID: 30966361
[TBL] [Abstract][Full Text] [Related]
39. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
40. Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma.
Devlin JR; Hannan KM; Hein N; Cullinane C; Kusnadi E; Ng PY; George AJ; Shortt J; Bywater MJ; Poortinga G; Sanij E; Kang J; Drygin D; O'Brien S; Johnstone RW; McArthur GA; Hannan RD; Pearson RB
Cancer Discov; 2016 Jan; 6(1):59-70. PubMed ID: 26490423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]